Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 11,380 | 8,720 | 5,420 | 0 | 400 |
| Cost of Goods | 4,177 | 2,696 | 1,044 | 488 | N/A |
| Gross Profit | 7,203 | 6,024 | 4,376 | -488 | 400 |
| Operating Expenses | 21,033 | 29,753 | 27,331 | 24,018 | 23,192 |
| Operating Income | -13,653 | -23,033 | -22,911 | -24,018 | -22,792 |
| Interest Expense | 696 | 830 | 884 | 901 | 957 |
| Other Income | -5,842 | 6,790 | 3,120 | 4,561 | 148,094 |
| Pre-tax Income | -20,191 | -17,073 | -20,675 | -20,358 | 124,345 |
| Income Tax | N/A | 2 | -215 | -15,197 | 15,512 |
| Net Income Continuous | -20,191 | -17,075 | -20,460 | -5,161 | 108,833 |
| Net Income | $-20,191 | $-17,075 | $-20,460 | $-5,161 | $108,833 |
| EPS Basic Total Ops | -0.35 | -0.30 | -0.39 | -0.10 | 2.07 |
| EPS Basic Continuous Ops | -0.35 | -0.30 | -0.39 | -0.10 | 2.07 |
| EPS Diluted Total Ops | -0.35 | -0.30 | -0.36 | -0.10 | 1.71 |
| EPS Diluted Continuous Ops | -0.35 | -0.30 | -0.22 | -0.10 | 1.63 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | -0.34 | -0.10 | -0.58 |
| EBITDA(a) | $-12,820 | $-22,164 | $-21,819 | $-23,130 | $-22,024 |